Angiotensin-(1-7) attenuates diabetic nephropathy in Zucker diabetic fatty rats - PubMed (original) (raw)
. 2012 Jun 15;302(12):F1606-15.
doi: 10.1152/ajprenal.00063.2012. Epub 2012 Apr 4.
Affiliations
- PMID: 22492942
- DOI: 10.1152/ajprenal.00063.2012
Free article
Angiotensin-(1-7) attenuates diabetic nephropathy in Zucker diabetic fatty rats
Jorge F Giani et al. Am J Physiol Renal Physiol. 2012.
Free article
Abstract
Angiotensin (ANG)-(1-7) is known to attenuate diabetic nephropathy; however, its role in the modulation of renal inflammation and oxidative stress in type 2 diabetes is poorly understood. Thus in the present study we evaluated the renal effects of a chronic ANG-(1-7) treatment in Zucker diabetic fatty rats (ZDF), an animal model of type 2 diabetes and nephropathy. Sixteen-week-old male ZDF and their respective controls [lean Zucker rats (LZR)] were used for this study. The protocol involved three groups: 1) LZR + saline, 2) ZDF + saline, and 3) ZDF + ANG-(1-7). For 2 wk, animals were implanted with subcutaneous osmotic pumps that delivered either saline or ANG-(1-7) (100 ng·kg(-1)·min(-1)) (n = 4). Renal fibrosis and tissue parameters of oxidative stress were determined. Also, renal levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), ED-1, hypoxia-inducible factor-1α (HIF-1α), and neutrophil gelatinase-associated lipocalin (NGAL) were determined by immunohistochemistry and immunoblotting. ANG-(1-7) induced a reduction in triglyceridemia, proteinuria, and systolic blood pressure (SBP) together with a restoration of creatinine clearance in ZDF. Additionally, ANG-(1-7) reduced renal fibrosis, decreased thiobarbituric acid-reactive substances, and restored the activity of both renal superoxide dismutase and catalase in ZDF. This attenuation of renal oxidative stress proceeded with decreased renal immunostaining of IL-6, TNF-α, ED-1, HIF-1α, and NGAL to values similar to those displayed by LZR. Angiotensin-converting enzyme type 2 (ACE2) and ANG II levels remained unchanged after treatment with ANG-(1-7). Chronic ANG-(1-7) treatment exerts a renoprotective effect in ZDF associated with a reduction of SBP, oxidative stress, and inflammatory markers. Thus ANG-(1-7) emerges as a novel target for treatment of diabetic nephropathy.
Similar articles
- Prevention of diabetic nephropathy by compound 21, selective agonist of angiotensin type 2 receptors, in Zucker diabetic fatty rats.
Castoldi G, di Gioia CR, Bombardi C, Maestroni S, Carletti R, Steckelings UM, Dahlöf B, Unger T, Zerbini G, Stella A. Castoldi G, et al. Am J Physiol Renal Physiol. 2014 Nov 15;307(10):F1123-31. doi: 10.1152/ajprenal.00247.2014. Epub 2014 Sep 3. Am J Physiol Renal Physiol. 2014. PMID: 25186297 - Angiotensin 1-7 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicity.
Mori J, Patel VB, Ramprasath T, Alrob OA, DesAulniers J, Scholey JW, Lopaschuk GD, Oudit GY. Mori J, et al. Am J Physiol Renal Physiol. 2014 Apr 15;306(8):F812-21. doi: 10.1152/ajprenal.00655.2013. Epub 2014 Feb 19. Am J Physiol Renal Physiol. 2014. PMID: 24553436 - Angiotensin-(1-7) reduces proteinuria and diminishes structural damage in renal tissue of stroke-prone spontaneously hypertensive rats.
Giani JF, Muñoz MC, Pons RA, Cao G, Toblli JE, Turyn D, Dominici FP. Giani JF, et al. Am J Physiol Renal Physiol. 2011 Jan;300(1):F272-82. doi: 10.1152/ajprenal.00278.2010. Epub 2010 Oct 20. Am J Physiol Renal Physiol. 2011. PMID: 20962118 - Chronically increased intrarenal angiotensin II causes nephropathy in an animal model of type 2 diabetes.
Sharma R, Sharma M, Reddy S, Savin VJ, Nagaria AM, Wiegmann TB. Sharma R, et al. Front Biosci. 2006 Jan 1;11:968-76. doi: 10.2741/1853. Front Biosci. 2006. PMID: 16146787 Review. - Mechanisms Leading to Differential Hypoxia-Inducible Factor Signaling in the Diabetic Kidney: Modulation by SGLT2 Inhibitors and Hypoxia Mimetics.
Packer M. Packer M. Am J Kidney Dis. 2021 Feb;77(2):280-286. doi: 10.1053/j.ajkd.2020.04.016. Epub 2020 Jul 23. Am J Kidney Dis. 2021. PMID: 32711072 Review.
Cited by
- The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).
Santos RAS, Sampaio WO, Alzamora AC, Motta-Santos D, Alenina N, Bader M, Campagnole-Santos MJ. Santos RAS, et al. Physiol Rev. 2018 Jan 1;98(1):505-553. doi: 10.1152/physrev.00023.2016. Physiol Rev. 2018. PMID: 29351514 Free PMC article. Review. - Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets.
Jiang F, Yang J, Zhang Y, Dong M, Wang S, Zhang Q, Liu FF, Zhang K, Zhang C. Jiang F, et al. Nat Rev Cardiol. 2014 Jul;11(7):413-26. doi: 10.1038/nrcardio.2014.59. Epub 2014 Apr 29. Nat Rev Cardiol. 2014. PMID: 24776703 Free PMC article. Review. - ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis.
Simões e Silva AC, Silveira KD, Ferreira AJ, Teixeira MM. Simões e Silva AC, et al. Br J Pharmacol. 2013 Jun;169(3):477-92. doi: 10.1111/bph.12159. Br J Pharmacol. 2013. PMID: 23488800 Free PMC article. Review. - Long-Term Administration of Angiotensin (1-7) to db/db Mice Reduces Oxidative Stress Damage in the Kidneys and Prevents Renal Dysfunction.
Papinska AM, Rodgers KE. Papinska AM, et al. Oxid Med Cell Longev. 2018 Oct 23;2018:1841046. doi: 10.1155/2018/1841046. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 30425780 Free PMC article. - International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].
Karnik SS, Unal H, Kemp JR, Tirupula KC, Eguchi S, Vanderheyden PM, Thomas WG. Karnik SS, et al. Pharmacol Rev. 2015 Oct;67(4):754-819. doi: 10.1124/pr.114.010454. Pharmacol Rev. 2015. PMID: 26315714 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous